跳至主要内容
临床试验/EUCTR2010-021665-68-BE
EUCTR2010-021665-68-BE进行中(未招募)不适用

Comparison of Slow Efficiency dialysis (SLEDD) with Unfractionated Heparin versus Citrasate in Critically Ill Patients

niversity Hospital Antwerp0 个研究点开始时间: 2010年9月20日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • ? Need for hemodialysis in the ICU for at least one treatment
  • ? No prior hemodialysis treatment in the ICU except continuous renal replacement therapy
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • ? Need for systemic anticoagulation with unfractionated or fractionated heparin, oral anticoagulants or intravenous anti-aggregants for other reasons
  • ? Need for continued thrombolysis therapy within the 6 hours before inclusion
  • ? Need for continued treatment with activated protein C (drotrecogin alfa) within the 12 hours before inclusion
  • ? Need for continued treatment with intravenous anti-aggregants (abciximab, eptifabide) withing 12 hours before inclusion
  • ? Liver failure (acute and acute-on-chronic)
  • ? Confirmed or suspected Heparin Induced Thrombocytopenia (HIT)
  • ? Heparin allergies
  • ? Severe uncorrected hypocalcemia (ionized calcium < 0,8 mmol/l)
  • ? Refusal of informed consent

研究者

发起方
niversity Hospital Antwerp

相似试验